Please login to the form below

Not currently logged in
Email:
Password:

antimicrobial

This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.

UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D

UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D

The UK government has taken a lead among nations in addressing the growing dangers of ‘superbugs’ and antimicrobial resistance (AMR) with the need for new classes of antimicrobials one of the ... which raised 1.5m in March for its proprietary

Latest news

More from news
Approximately 40 fully matching, plus 64 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    dementia and antimicrobials. ... It is focusing on four areas of acute medical and societal need where it believes healthcare comms can play a big role: antimicrobial resistance, mental health, obesity and precision medicine.

  • Combining therapies and combining research Combining therapies and combining research

    Antimicrobial resistance (AMR) is a complex issue of global concern that has the potential to void advances in modern medicine. ... There are growing concerns about the lack of new drug development surrounding antimicrobial resistance.

  • Rules of engagement Rules of engagement

    Fewer than half of the nearly 10, 000 respondents had heard of the term ‘antimicrobial resistance’.

  • No incentive for a cure No incentive for a cure

    The stakes are too high for this not to happen. The risk we face from antimicrobial resistance and the current lack of new antibiotics tells us all we need to know

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Why this issue is such a fundamental challenge. A look at some of the headline statistics on the antimicrobial resistance (AMR) issue is particularly sobering. ... market. About the AMR Centre. The AMR Centre is a key part of the UK’s response to the

More from intelligence
Approximately 6 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Mobilising the public to combat the antimicrobial resistance crisis

    Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.

  • Navigating the antibiotic resistance crisis

    Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,

  • Antibiotic Resistance: Alarm bells ring louder than ever

    where antibiotics and the threat of antimicrobial resistance (AMR) became a hot topic in the mainstream media. ... Another angle is the development of small molecules that can be administered in conjunction with antimicrobials to prevent resistance

  • Cello Health

    Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be discovered

  • Blue Latitude Health

    Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...

Infographics